Senior Medical Director
Revolution MedicinesRedwood City, California, United States
Posted April 10, 2026
244000 - 305000 USD
Full Time
About the Company
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers.
Job Description
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development.
Requirements
- M.D. or M.D./Ph.D. with relevant clinical training required
- Minimum 13+ years’ experience in pharma/biotech clinical development OR is a recognized expert in the field
- Experience working with the principles and techniques of data analysis, interpretation, and clinical relevance
Benefits
- Competitive cash compensation
- Robust equity awards
- Strong benefits
- Significant learning and development opportunities